Skip to main content Skip to main navigation menu Skip to site footer

Candida auris as a pathogen that can cause emerging infectious disease: a literature review

Abstract

Candida auris is a fungal pathogen that can cause emerging infectious disease and infections related to health services (healthcare-associated infections) and threaten global health. It is one of the causes of candidemia, which has been connected to outbreaks and high mortality rates in medical facilities all over the world. Hospitalized patients who are critically ill, primarily in intensive care unit settings, account for the majority of reported infections. C. auris can be multi-resistant to various antifungal classes commonly used to treat other Candida infections. Invasive infection due to C. auris causes high mortality and morbidity rates. C. auris easily survives long enough in the surrounding environment to cause the rapid spread of outbreaks in health facilities. The critical need for novel, candidate antifungal medicines for C. auris therapies is driven by the pathogenicity, drug resistance, and widespread distribution of C. auris. In limiting the spread of C. auris, prompt investigations and aggressive interventions are required. These include alerting public health agencies, implementing contact precautions, thoroughly cleaning and disinfecting the environment, performing infection control assessments, tracing and screening contacts for colonization, reviewing the history of microbiology tests, and conducting prospective surveillance for cases at labs. C. auris poses a unique challenge in clinical settings due to its identification challenges, multidrug resistance traits, evolution of virulence factors, associated high patient fatality rates, and long-term survival on surfaces in the environment. This study aims to understand the epidemiology, clinical manifestations, characteristics, virulence factors, methods of identification, therapy and prevention control of infection by C. auris.

References

  1. Ahmad S, Alfouzan W. Candida auris: Epidemiology, diagnosis, pathogenesis, antifungal susceptibility, and infection control measures to combat the spread of infections in healthcare facilities. Microorganisms. 2021;9(4).
  2. Egger NB, Kainz K, Schulze A, Bauer MA, Madeo F, Carmona-Gutierrez D. The rise of Candida auris: from unique traits to co-infection potential. Microb Cell. 2022;9(8):141-144.
  3. Zhu Y, O'Brien B, Leach L, et al. Laboratory Analysis of an Outbreak of Candida auris in New York from 2016 to 2018: Impact and Lessons Learned. J Clin Microbiol. 2020;58(4):e01503-19.
  4. Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlina DS. Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida auris. J Clin Microbiol. 2017;55(8):2445-2452.
  5. Alvarado M, Bartolomé Álvarez J, Lockhart SR, et al. Identification of Candida auris and related species by multiplex PCR based on unique GPI protein-encoding genes. Mycoses. 2021;64(2):194-202.
  6. Ruiz-Gaitán AC, Fernández-Pereira J, Valentin E, et al. Molecular identification of Candida auris by PCR amplification of species-specific GPI protein-encoding genes. Int J Med Microbiol. 2018;308(7):812-818.
  7. Černáková L, Roudbary M, Brás S, Tafaj S, Rodrigues CF. Candida auris: A Quick Review on Identification, Current Treatments, and Challenges. Int J Mol Sci. 2021;22(9):4470.
  8. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41-44.
  9. Kim MN, Shin JH, Sung H, et al. Candida haemulonii and closely related species at 5 university hospitals in Korea: Identification, antifungal susceptibility, and clinical features. Clin Infect Dis. 2009;48(6):57-61.
  10. Lee WG, Shin JH, Uh Y, et al. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol. 2011;49(9):3139-3142.
  11. Chybowska AD, Childers DS, Farrer RA. Nine Things Genomics Can Tell Us About Candida auris. Front Genet. 2020;11:1-18.
  12. Cortegiani A, Misseri G, Fasciana T, Giammanco A, Giarratano A, Chowdhary A. Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. J Intensive Care. 2018;6(1):1-13.
  13. Allert S, Schulz D, Kämmer P, et al. From environmental adaptation to host survival: Attributes that mediate pathogenicity of Candida auris. Virulence. 2022;13(1):191-214.
  14. Rossato L, Colombo AL. Candida auris: What have we learned about its mechanisms of pathogenicity? Front Microbiol. 2018;9(DEC):1-6.
  15. Jeffery-Smith A, Taori SK, Schelenz S, et al. Candida auris: A review of the literature. Clin Microbiol Rev. 2018;31(1):1-18.
  16. Mba IE, Nweze EI. Mechanism of Candida pathogenesis: revisiting the vital drivers. Eur J Clin Microbiol Infect Dis. 2020;39(10):1797-1819.
  17. Dennis EK, Chaturvedi S, Chaturvedi V. So Many Diagnostic Tests, So Little Time: Review and Preview of Candida auris Testing in Clinical and Public Health Laboratories. Front Microbiol. 2021;12:757835.
  18. Chow NA, Muñoz JF, Gade L, et al. Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses. mBio. 2020;11(2):e03364-19.
  19. Parwanto E, Wratsangka R, Guyansyah A, Anggraeni K, Digambiro RA, Tjahyadi D, Arkeman H, Widyatama HG, Edy HJ, Edy, YJ. The change of cell biometric and its nucleus on cervical-squamous-epithelial-cell with GA genotype of Fas-promoter-670 gene, high-risk human papillomavirus and Candida species infection: a case report. Bali Medical Journal. 2021;10(1): 74-81.
  20. Leach L, Zhu Y, Chaturvedi S. Development and validation of a real-time PCR assay for rapid detection of Candida auris from surveillance samples. J Clin Microbiol. 2018;56(2).
  21. CDC. Recommendations for treatment of Candida auris infections. Published 2021. https://www.cdc.gov/fungal/candida-auris/c-auris-treatment.html
  22. Wang X, Bing J, Zheng Q, et al. The first isolate of Candida auris in China: Clinical and biological aspects article. Emerg Microbes Infect. 2018;7(1):0-8.
  23. Escandón P, Chow NA, Caceres DH, et al. Molecular epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization with Regional Patterns in Amphotericin B Resistance. Clin Infect Dis. 2019;68(1):15-21.
  24. Kumar J, Eilertson B, Cadnum JL, et al. Environmental contamination with candida species in multiple hospitals including a tertiary care hospital with a Candida auris outbreak. Pathog Immun. 2019;4(2):260-270.
  25. Caceres DH, Forsberg K, Welsh RM, et al. Candida auris: A Review of Recommendations for Detection and Control in Healthcare Settings. J Fungi (Basel). 2019;5(4):111.
  26. He Z, Chen J, Li W, Cheng Y, Zhang H, Zhang L, Hou T. Serological response value and diagnostic value of recombinant candida cell wall protein enolase, phosphoglyceratekinase, and -glucosidase. Front Microbiol. 2015;6:920.
  27. Noviyanti, Martiani I, Perdana F, Rahmaniah. Determination of total phenol and total flavonoid, and antioxidant activities of chocolate leaves (Zephyranthes candida (Lindl.) Herb.). Bali Medical Journal. 2022;11(2): 927-933.
  28. Kohlenberg A, Monnet DL, Plachouras D; Candida auris survey collaborative group; Candida auris survey collaborative group includes the following national experts. Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021. Euro Surveill. 2022;27(46):2200846.
  29. Armayanti I, Wardani MK, Nasution LH. The effect of cutaneous candidiasis toward skin moisture in Haji Adam Malik Central Hospital in Medan. Bali Medical Journal. 2021;10(2):802-806.
  30. Gómez-Gaviria M, Martínez-Álvarez JA, Chávez-Santiago JO, Mora-Montes HM. Candida haemulonii Complex and Candida auris: Biology, Virulence Factors, Immune Response, and Multidrug Resistance. Infect Drug Resist. 2023;16:1455-1470.
  31. Vila T, Sultan AS, Montelongo-Jauregui D, Jabra-Rizk MA. Candida auris: a fungus with identity crisis. Pathog Dis. 2020;78(4):ftaa034.
  32. de Jong AW, Dieleman C, Carbia M, Mohd Tap R, Hagen F. Performance of Two Novel Chromogenic Media for the Identification of Multidrug-Resistant Candida auris Compared with Other Commercially Available Formulations. J Clin Microbiol. 2021;59(4):e03220-20.
  33. Kämmer P, McNamara S, Wolf T, et al. Survival Strategies of Pathogenic Candida Species in Human Blood Show Independent and Specific Adaptations. mBio. 2020;11(5):e02435-20.
  34. Fidler G, Leiter E, Kocsube S, Biro S, Paholcsek M. Validation of a simplex PCR assay enabling reliable identification of clinically relevant Candida species. BMC Infect Dis. 2018;18(1):393.
  35. Du H, Bing J, Hu T, Ennis CL, Nobile CJ, Huang G. Candida auris: Epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog. 2020;16(10):e1008921.

How to Cite

Arthisari, N. N. N. ., Budayanti, N. N. S. ., & Tarini, N. M. A. . (2023). Candida auris as a pathogen that can cause emerging infectious disease: a literature review. Intisari Sains Medis, 14(1), 394–400. https://doi.org/10.15562/ism.v14i1.1679

HTML
0

Total
0

Share

Search Panel

Ni Nyoman Nami Arthisari
Google Scholar
Pubmed
ISM Journal


Ni Nyoman Sri Budayanti
Google Scholar
Pubmed
ISM Journal


Ni Made Adi Tarini
Google Scholar
Pubmed
ISM Journal